Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)

Nitesh sinha January 25, 2024

https://ift.tt/Aqzhbya

from Sanofi - Aventis Groupe https://ift.tt/PQMzayZ
via IFTTT

health care